Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

about

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

Item

http://www.wikidata.org/entity/Q58201176

description

im September 2010 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2010

@uk

name

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

@en

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

@nl

type

Item

label

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

@en

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

@nl

prefLabel

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

@en

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

@nl

P1476

Serum Proteome Pool Changes in Type 2 Diabetic Patients Treated with Anakinra

@en

P2093

Allan Vaag

http://www.w3.org/2001/XMLSchema#string

Claus M. Larsen

http://www.w3.org/2001/XMLSchema#string

James Norton McGuire

http://www.w3.org/2001/XMLSchema#string

Jan A. Ehses

http://www.w3.org/2001/XMLSchema#string

Marc Y. Donath

http://www.w3.org/2001/XMLSchema#string

Mette Koefoed

http://www.w3.org/2001/XMLSchema#string

Mirjam V. Faulenbach

http://www.w3.org/2001/XMLSchema#string

P2860

Retinol-binding protein 4 in human obesity

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Use of proteomic patterns in serum to identify ovarian cancer.

The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes

Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid.

ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke.

Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population.

Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum.

Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.

P2888

s12014-010-9056-x

P304

153-161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12014-010-9056-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Mandrup-Poulsen

Flemming Pociot

P577

2010-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime